Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P42
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 5.74% |
| 2024 | 38.19% |
| 2023 | 51.69% |
| 2022 | -17.65% |
| 2021 | -32.15% |
| 2020 | -9.17% |
| 2019 | 84.48% |
| 2018 | 4.25% |
| 2017 | 47.36% |
| 2016 | 52.64% |